Editor’s Note: This was published in Pharmaceutical Technology Europe’s June 2021 print issue.
|Articles|June 2, 2021
- Pharmaceutical Technology, June 2021 Issue
- Volume 45
- Issue 6
Analyzer for Pure Water Applications
Shimadzu released the TOC-1000e, an analyzer in the eTOC series of on-line TOC analyzers formulated for pure water applications.
Shimadzu released the TOC-1000e, an analyzer in the eTOC series of on-line TOC analyzers formulated for pure water applications. With a focus on miniaturization, high sensitivity, and a mercury-free oxidation technique, the analyzer has a small, light cabinet that offers high-sensitivity detection for fields that require high-purity water applications.
With an “Active-Path” flow line design, the analyzer uses an excimer lamp rather than a mercury lamp to integrate sample flow channel and the light source. This lessens sample residue in the flow channel and removes intrusive air layers, so high sensitivity is maintained over long-term use.
Additionally, the analyzer can be installed as table-top, wall-mounted, or pole-mounted. It provides high sensitivity with a detection limit of 0.1 μg/L; it contains consumable parts that can be removed and installed without tools; and it is compliant with regulatory requirements through its highly sensitive UV oxidation-conductivity method for ultra-pure water monitoring.
Articles in this issue
over 5 years ago
New Biotherapies Push Technological Innovation Forwardover 5 years ago
Assessing Risk and Production of Potent Substancesover 5 years ago
Moving Beyond Particle Size Controlover 5 years ago
Cleaning Continuous Manufacturing Equipmentover 5 years ago
Considering Robotics for Drug Compoundingover 5 years ago
Considerations for Cleaning Biopharmaceutical Process Equipmentover 5 years ago
Navigating International Pharmacovigilanceover 5 years ago
Prioritizing Cleaning Validationover 5 years ago
Developing a Method for Success through PartnershipsRelated to this article
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
Karthik Iyer, Eli Lilly, details an AI system linking GMP findings, audits, and deviations for cited, inspection-ready regulatory intelligence.
At the PDA/FDA Joint Regulatory Conference 2026, Helen Motamen, MS
global head, Sanofi Quality Audit, Inspection, Intelligence & Advocacy, at Sanofi, provided advice for creating a strong internal audit program.
At PDA/FDA Joint Regulatory Conference 2026, PCI Pharma's Bassler details how a QMS overhaul turned an FDA 483 into stronger quality culture.
Trending on Pharmaceutical Technology
1
Driving Quality Culture to Manage Risk: Lessons from an FDA Inspection Response
2
FDA's IND Pilot Puts CMC Review First
3
Mature Medicines Divestment Signals Shift in Manufacturing Strategy
4
Spray Drying Capacity Signals Faster Paths for Poorly Soluble Drugs
5